Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced the onset of a new membership service by its subsidiaries Bonum Health and DelivMeds. According to the update, the monthly subscription rate of $19.95 now includes an option of three (3) premium visits per month as well as free prescription … Continue reading “NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces New Membership Service by Bonum Health and DelivMeds Subsidiaries”
Trxade Group has captured nearly half of the independent pharmacy market with its web-based purchasing platform “E-Bay/Kayak-like” Supplier-to-Pharmacy trading platform improves transaction processing between independent pharmacists and drug distributors Predictive data analytics features, price visibility and profit optimization within the platform are critical as the general population ages Trxade Group Inc. (NASDAQ: MEDS) is an … Continue reading “Trxade Group Inc. (NASDAQ: MEDS) Captures Significant Independent Pharmacy Market Share and Continues Steady Growth in 2020”
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables drug availability, care services and price transparency for both pharmacists and consumers, today announced that it will exhibit at HIMSS 2020. The event, which will draw over 45,000 healthcare professionals, is slated to take place at the Orange County Convention center … Continue reading “NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) to Exhibit at HIMSS 2020 Global Health Conference & Exhibition”
Trxade Group (NASDAQ: MEDS) announced that the company’s chief executive officer Suren Ajjarapu will ring the Nasdaq opening bell at 9:30 AM ET on February 28, 2020, signifying the start of trade. Trxade Group is an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and … Continue reading “NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) CEO Rings Nasdaq Opening Bell”
Pharmaceutical services business Trxade Group Inc. recently announced its uplisting to the Nasdaq Capital Market and will ring the exchange’s opening bell this Friday, February 28, 2020 The ringing of the opening bell will be broadcast live at 9:30 a.m. EST from the Nasdaq’s Times Square market site in New York City The company will … Continue reading “Trxade Group Inc. (NASDAQ: MEDS) to Celebrate Nasdaq Uplisting with Opening Bell on Friday”
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, today announced the exercise by the underwriters of the Company’s previously announced firm commitment underwritten offering which closed on February 18, 2020. According to the update, the … Continue reading “NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Underwriters Exercise of Overallotment Option”
Trxade announces pricing of a firm commitment public offering of 806,452 shares of its common stock Proceeds to be used as working capital and to fund future acquisitions Company’s B2B online purchasing platform currently has 11,900 pharmacies registered and is registering 100+ New pharmacies per month Trxade Group Inc. (NASDAQ: MEDS), an integrated drug delivery, … Continue reading “Trxade Group Inc. (NASDAQ: MEDS) Uplists to Nasdaq, Expects Gross Proceeds of $5.2M from Common Stock Sale”
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, on Tuesday announced the closing of its underwritten public offering of 806,452 shares of common stock at a price to the public of $6.50 each. The company granted … Continue reading “NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Closes Firm Commitment Common Stock Offering”
Trxade Group (NASDAQ: MEDS) (OTCQB: TRXD), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, this morning announced that its common stock will today begin trading on the Nasdaq Capital Market under the new symbol ‘MEDS’. In connection with the company’s … Continue reading “NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) (OTCQB: TRXD) Announces Nasdaq Uplisting, Pricing of $5.2M Firm Commitment Public Offering, Effectiveness of Reverse Stock Split”
Trxade targeting all 24,000 independent pharmacies across the U.S., with total purchases of $93 billion a year Company’s online platform currently has about 11,500 pharmacies as registered users and grows by roughly 100 users every month Proceeds from IPO to be used as working capital and to fund future acquisitions Business-to-business pharmacy services supplier Trxade … Continue reading “Integrated Pharma Supply Chain and Care Platform Trxade Group, Inc. (NASDAQ: MEDS) (OTCQB: TRXD) Aims to Raise $5 Million in IPO Nasdaq Bid”
